Background: Diffusion MRI is one of the important technological advances that played a crucial role in the discovery of abnormalities related to schizophrenia. While other imaging modalities focused on volumetric changes, and on functional changes (e.g., metabolic, and vascular) diffusion MRI introduced the ability to study microstructural changes. Most diffusion MRI studies focused especially on the white matter, where the diffusion tensor imaging (DTI) analysis, which by now is considered widely available and conventional, provided unique microstructural contrasts. The most important parameter has been the fractional anisotropy (FA), which was perceived as a white matter integrity measure, and sometimes as a myelin integrity measure. The simplicity of the DTI model, and its growing availability on clinical scanners resulted with a considerable body of work demonstrating reduced FA in schizophrenia, leading to new clinical hypotheses, suggesting that mental disorders may involve white matter deficiency, which in turn would lead to mis-wiring, and connectivity issues that may explain some of the unusual symptoms associated with schizophrenia. However, even though DTI measures, and specifically FA, appear to be very sensitive to subtle brain changes, these measures are not specific to any pathology. In fact, while clinical studies attempted to relate DTI measures with white matter and myelin integrity, methodological studies provided clearer evidence that such a relationship is not warranted, since DTI measures could be affected by multitude of sources. This methodological complication raised the need for more advanced microstructural imaging, which could provide superior specificity to underlying pathologies, and especially to pathologies that are related to white matter integrity and connectivity. Methods: In the recent years advanced diffusion acquisition and modeling approaches became available, leading to a significant number of studies that have applied these new tools on psychosis populations. Tools include biological model-based approaches such as free-water imaging, NODDI and permeability-diffusivity index. Other tools select model free approaches such as Kurtosis imaging, Q-space imaging, Diffusion spectrum imaging, and Generalized FA. The advanced methods provide new ways to characterize abnormalities, but at the same time, as the models become more complicated, so are the acquisitions, their length, and their sensitivity to noise. This talk will review findings from advanced diffusion MRI methods and will compare them with those obtained by the conventional DTI approach. Results: The comparison shows that while the sensitivity to identify abnormalities is not necessarily increased by the advanced methods, the fact that in some of these approaches the specificity is improved provides new insights into the nature of the underlying abnormalities. Nevertheless, even though specificity is improved, care must be taken with the interpretation of the result given the fact that diffusion MRI is an indirect measure of microstructure, limited by the assumption embedded in each model. Discussion: The emerging results present dependency on the stage of the psychosis (e.g., first episode, chronic) as well as on the age and gender of the subjects, suggesting that care must be taken in the study design, as well as in the statistical analyses performed. The findings also promote the use of multi-modal acquisitions, as well as the collection of biological, clinical and cognitive parameters. The combined information of these different domains is more likely to truly characterize the underlying abnormalities.
EEG AS A TOOL FOR PSYCHOSIS RESEARCH: CHALLENGES, PITFALLS AND NEW OPPORTUNITIES
Christoph Mulert* ,1
University Hospital Hamburg Eppendorf
Background: Electroencephalography (EEG) as the oldest technique currently in use for the analysis of brain function has strong advantages not offered by other techniques: it is a direct measurement of neuronal activity and offers a high temporal resolution. Accordingly, it is very useful for the investigation of neuronal oscillations which are related to disturbed core mechanisms of schizophrenia such as NMDA-receptor dysfunction or E/I imbalance and alterations in connectivity. Methods: On the other hand, the method has also strong limitations, e.g. the difficulty of precise localization, which is due to the inverse problem and also its blindness to subcortical structures that are highly relevant for psychosis research, such as the ventral striatum. Results: Uncritical use of this technique has created widespread skepticism, leading probably to some degree of underestimation of the unique opportunities offered. In this talk, limitations of the technique will be addressed as well as current strategies of proper usage such as the combination of EEG and fMRI. Discussion: Simultaneous EEG-fMRI offers the best from both modalities, that is high temporal and high spatial resolution, but here, too, methodological challenges have to be addressed. Finally, the development of new noninvasive tools for brain stimulation such as transcranial alternating current stimulation (tACS) with the opportunity of frequency-specific modulation of neuronal oscillations ("entrainment") for both brain research and therapy makes detailed information about disturbed oscillations patterns in psychosis even more relevant.
BRAIN FUNCTIONAL CONNECTOMICS BASED ON RESTING STATE FMRI: FROM NODES TO NETWORKS
Juan Zhou* ,1
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Background: Emerging evidence suggests that psychosis arises from disrupted communication between distributed neural networks. In the past decade, network-sensitive neuroimaging methods have made it possible to examine vulnerable brain networks in living humans. Previous work has demonstrated that distinct functional intrinsic connectivity networks can be mapped in the healthy brain with task-free or "resting-state" functional magnetic resonance imaging (fMRI). Instead of the changes evoked by specific stimuli, resting state fMRI captures the spontaneous low frequency blood-oxygenation-level-dependent signal fluctuations at rest. Regions showing synchronized spontaneous activities are usually functionally connected and are often supporting highly relevant brain functions. Being more applicable in patients, recent resting state fMRI studies in psychosis have reported widespread functional dysconnectivity, targeting multiple neural systems that include the default mode network, the salience network, the auditory network, and fronto-striato-thalamic circuits. Such functional connectivity disruptions are also associated with more severe symptoms and more cognitive impairments in patients. Methods: In this talk, I will cover four primary methods for deriving functional connectivity from resting state fMRI data and discuss their pros and cons in the context of schizophrenia. 1) Seed-based approach: correlation between signals of a seed region to other target regions or with the rest of the brain. 2) Independent component analysis: decompose the fMRI data of all brain voxels into spatially non-overlapping and temporally coherent networks. 3) Brain parcellation-based connectivity matrices: based on a set of predefined regions of interest covering the whole brain, the functional connectivity between all pairs of regions are computed and the individual-level connectivity matrices are compared. Lastly, 4) graph theoretical approach is highly useful in capturing and visualizing complex brain interactions embedded in these high dimensional matrices. In a brain graph, each ROI is a node and the functional connectivity between a pair of ROIs is an edge. Graph theoretical measures can then capture the brain functional topology such as functional segregation or modularity at nodal, network, and whole-brain levels.
Results: By modelling connectivity as complex networks, this talk will shed some light on whether functional connectomics based on resting state fMRI could 1) reveal symptoms-associated brain network changes; 2) detect early changes in prodromal stage of the disease; 3) predict clinical outcomes in psychosis. Particularly, work from our group and others on persons at-risk for psychosis will be discussed. Moreover, accumulating evidence suggests the influence of vigilance, motion, and physiological noise on functional connectivity measures. I will provide some tips on how to minimize these confounds and increase the reliability and reproducibility of functional connectomics measures. Discussion: Resting state fMRI provides a novel network-sensitive, immediately repeatable, non-invasive tool to examine human functional connectome. Future directions such as dynamic or time-varying functional connectivity which captures neural dynamics at a finer time scale will be briefly discussed. Further developed and integrated with brain structural connectivity measures, brain network functional connectomics may help us better understand heterogeneity in psychosis, reveal disease mechanism, predict and track disease progression, and monitor treatment response.
RETINAL FUNCTIONS EXPRESSED IN RETINAL IMAGING, CONTRAST PROCESSING AND ELECTRORETINOGRAPHY MAY DECRYPT EARLY RISK MECHANISMS AND PATHOPHYSIOLOGY OF SCHIZOPHRENIA AND MOOD DISORDERS AND ACCELERATE TRANSLATION TO THE CLINIC Michel Maziade Centre de recherche CIUSSS de la Capitale-Nationale
Overall Abstract: The rationale of this symposium is twofold. First, true understanding of the neurobiological and environmental causes of schizophrenia and mood disorders will require the investigation of the human neuronal tissue in function. As an external and accessible extension of the brain, the retina opens this avenue. Existing technologies such as retinal imaging, computerized psychophysical assessment, and electroretinography (ERG) have recently provided evidence that the microanatomy of the retina and strength of rod, cone, and bipolar cell responses to light stimuli can distinguish patients from healthy individuals (Adams & Nasrallah, Schizophr Res 2017; Silverstein & Rosen, Schizophr Res Cogn 2015; Bubl, Biol Psychiatry, 2010; Plos ONE, 2015, Meier, Am J Psychiatry 2014). Second, the search for indicators of brain dysfunction that are detectable both in adult patients and in children at genetic risk is the cornerstone of genetic high-risk research into the neurodevelopmental origins of serious mental disorders and prevention (Maziade, New Eng J Med 2017). In this regard, it has been shown that children at genetic risk show many of the retinal anomalies that adult patients display (Hébert et al., 2010, Biol Psychiatry) . Studies of the retina can therefore contribute to clarifying illness pathophysiology and its developmental roots. This symposium objectives are to: 1) present findings from retinal imaging, visual processing and electroretinography in patients with schizophrenia or mood disorders, and in young healthy offspring of affected parents; 2) to discuss the data in terms of their implications for understanding psychotic and mood disorders; and 3) to clarify the similarities and differences between retinal findings in psychotic and mood disorders and their early developmental trajectories. Participating scientists: Professor Michel Maziade will be the chair, with Professor Steven Silverstein as the co-chair of the symposium. Professor Anne Giersh, INSERM Strasbourg, France, will act as the discussant. Professor Emanuel Bubl, Saarland University, Germany, will present findings on the potential of ERG measured retinal background noise as neurobiological correlate for cognitive deficits in ADHD and schizophrenia. Professor Maziade, Laval University, Canada, will present new ERG findings in young offspring of parents affected by schizophrenia or bipolar disorder and the implications for the illness developmental origin and later transition to illness. Professor Madeline Meier, Arizona State University, USA, will present results showing phenotypic and genetic associations between schizophrenia and retinal vessel diameter. Findings suggest that individuals with schizophrenia are at increased risk of microvascular complications. Professor Silverstein, Rutgers University, USA, will present new ERG findings in schizophrenia, and data on the relationships between ERG anomalies, symptoms, retinal structural abnormalities as measured with optical coherence tomography, and antipsychotic medication use. Based on empirical data, the symposium will offer an integrated view as to: i) how non-invasive measurements of retinal structure and function show consistent anomalies in schizophrenia, bipolar disorder, major depression and ADHD; ii) how findings from children and adolescents at high genetic risk not only indicate a neurodevelopmental process, but also suggest that retinal anomalies in patients are not due to medication use or degenerative effects; iii) how ERG can be administered to adults and children at low cost in clinical studies; iv) how to integrate findings in the staging of the risk status of children at genetic risk. 
ELECTRORETINOGRAPHIC ANOMALIES IN

Rutgers University
Background: Although several studies have documented retinal cell dysfunction in schizophrenia (Silverstein & Rosen, Scz Res: Cogn, 2015) , the extent to which these abnormalities contribute to, and/or result from, other features of the condition is unclear. Thus we sought to: 1) evaluate associations between retinal signaling anomalies as measured with flash electroretinography (fERG) and previously reported changes in visual evoked potentials (VEPs), contrast sensitivity, visual acuity, and contour integration in people with schizophrenia (Silverstein, Neb Symp Motiv, 2016) ; 2) determine whether fERG anomalies are related to retinal structural abnormalities as indicated by optical coherence tomography (OCT); 3) examine relationships between fERG changes and psychiatric symptoms; 4) determine relationships between fERG anomalies and frequent medical comorbidities in schizophrenia that are known to affect the retina (e.g., diabetes, hypertension); and 5) examine potential medication effects on these findings.
Methods:
We have assessed 25 patients with schizophrenia and 25 controls who are free of medical comorbidity with fERG and measures of visual function and symptom severity, and data collection is ongoing with patients and controls with diabetes and/or hypertension using these same measures.
In addition, we are in the process of completing data collection with two additional groups of patients and controls, one with fERG and OCT (n=12 to date), and another with fERG and VEPs (n=13 to date). fERG data are being collected under both light-and dark-adapted conditions, using a range of flash intensities, backgrounds, and temporal frequencies. The primary fERG variables of interest are a-wave and b-wave amplitudes, which reflect photoreceptor and bipolar cell responses, respectively, and the photopic negative response (PhNR), which reflects ganglion cell activity. Results: On photopic fERG tests, patients with schizophrenia demonstrated significantly weaker photoreceptor response when a flash was presented against an unlit background (p<.05), and during a steady-state flicker test (p<.005). On scotopic tests, the rate of response gain per unit of intensity increase was significantly weaker for patients than controls (p=.001).
In both light-and dark-adapted conditions, patients demonstrated weaker
